MedTrace Logo

An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)

NCT02547454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 393

Last updated 2017-06-07

Study results available
· View outcomes & findings →

Summary

This observational trial will examine the efficacy and safety of Mircera for renal anemia in participants with stage III-IV CKD in daily clinical practice. Mircera will be prescribed by treating physician and followed for approximately 36 months.

Conditions

  • Kidney Disease, Chronic

Interventions

DRUG

Methoxy polyethylene glycol-epoetin beta

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02547454 on ClinicalTrials.gov